Zurich Insurance Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-65,870
Closed -$44.6M 344
2025
Q4
$44.6M Sell
65,870
-159,098
-71% -$108M 0.31% 85
2025
Q3
$144M Buy
+224,968
New +$137M 1.03% 18
2023
Q3
Sell
-98,374
Closed -$49.4M 266
2023
Q2
$49.4M Buy
98,374
+10,189
+12% +$4.88M 0.51% 66
2023
Q1
$44.1M Sell
88,185
-12,206
-12% -$5.84M 0.55% 71
2022
Q4
$41M Sell
100,391
-13,501
-12% -$5.24M 0.59% 64
2022
Q3
$37.1M Buy
113,892
+33,250
+41% +$12.2M 0.58% 60
2022
Q2
$28.3M Buy
80,642
+25,175
+45% +$10.3M 0.42% 82
2022
Q1
$30.3M Buy
+55,467
New +$29.2M 0.38% 72
2019
Q4
Sell
-15,141
Closed -$4.12M 353
2019
Q3
$4.12M Sell
15,141
-17,852
-54% -$4.97M 0.08% 270
2019
Q2
$9.08M Buy
32,993
+18,537
+128% +$4.57M 0.18% 160
2019
Q1
$3.23M Buy
14,456
+234
+2% +$48.3K 0.07% 250
2018
Q4
$2.65M Sell
14,222
-10,270
-42% -$2.11M 0.06% 235
2018
Q3
$6.12M Sell
24,492
-6,319
-21% -$1.53M 0.13% 193
2018
Q2
$6.71M Buy
+30,811
New +$6.35M 0.15% 196
2017
Q4
Sell
-5,012
Closed -$779K 598
2017
Q3
$779K Sell
5,012
-11,412
-69% -$1.8M 0.02% 575
2017
Q2
$2.65M Buy
+16,424
New +$2.67M 0.08% 316

Other funds holding IDXX

Zurich Insurance Group's IDXX Position: Q1 2026 in Review

Zurich Insurance Group sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 65,870 shares — an estimated $44.6M sold.

Zurich Insurance Group first reported a position in IDXX in Q2 2017 and held it in 16 quarters. The position peaked at $144M in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Zurich Insurance Group reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Zurich Insurance Group sold 65,870 Idexx Laboratories shares in Q1 2026, an estimated $44.6M.
  • Zurich Insurance Group first reported a position in Idexx Laboratories in Q2 2017 and held it in 16 quarters.
  • Zurich Insurance Group's Idexx Laboratories position peaked at $144M in Q3 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Zurich Insurance Group's 13F filing for Q1 2026, filed 15 May 2026.